Literature DB >> 21029129

Maximizing efficiency of alternation algorithms for hemodynamic optimization of the AV delay of cardiac resynchronization therapy.

Zachary I Whinnett1, Gemma Nott, Justin E R Davies, Keith Willson, Charlotte H Manisty, Prapa Kanagaratnam, Nicholas S Peters, D Wyn Davies, Alun D Hughes, Jamil Mayet, Darrel P Francis.   

Abstract

BACKGROUND: During optimization of the atrioventricular (AV) delay of cardiac resynchronization therapy (CRT), it is not known exactly which windows of time around the transition are most informative for identification of the optimum. METHOD AND
RESULTS: IN 22 patients with CRT, we performed AV delay optimization using continuous noninvasive hemodynamics. We used signal-to-noise ratio to determine the most efficient averaging window location and width. We found that it is most efficient to position the averaging windows immediately before and immediately after the transition in AV delay. For example, skipping five beats after the transition decreases signal-to-noise ratio by 17.5% (P < 0.0001). Similarly, skipping five beats immediately before the transition reduces signal-to-noise ratio by 11.7% (P < 0.0001). The best choice of "fixed" averaging window width was found to be six beats, with signal-to-noise ratio falling by, for example, 41% for a one-beat window (P = 0.0002). However, even better was to set the window width for each patient to match one respiratory cycle. We observed that the pre- and posttransition signal-to-noise ratio traces begin to diverge three beats after the transition in AV delay. We believe this represents the time taken for the peripheral response to pacing-induced changes in stroke volume to occur.
CONCLUSIONS: THE most efficient way to use alternating transitions for the hemodynamic optimization of CRT is to use an averaging window of one respiratory cycle, and not to skip any beats between the pretransition and posttransition averaging windows. ©2010, The Authors. Journal compilation ©2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21029129     DOI: 10.1111/j.1540-8159.2010.02933.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  8 in total

1.  Programming an optimal atrioventricular interval in a dual chamber pacemaker regional population.

Authors:  Cristian Statescu; Radu A Sascau; Vasile Maciuc; Catalina Arsenescu Georgescu
Journal:  Maedica (Buchar)       Date:  2011-10

2.  A systematic approach to designing reliable VV optimization methodology: assessment of internal validity of echocardiographic, electrocardiographic and haemodynamic optimization of cardiac resynchronization therapy.

Authors:  Andreas Kyriacou; Matthew E Li Kam Wa; Punam A Pabari; Beth Unsworth; Resham Baruah; Keith Willson; Nicholas S Peters; Prapa Kanagaratnam; Alun D Hughes; Jamil Mayet; Zachary I Whinnett; Darrel P Francis
Journal:  Int J Cardiol       Date:  2012-03-27       Impact factor: 4.164

3.  Cardiac resynchronization therapy and AV optimization increase myocardial oxygen consumption, but increase cardiac function more than proportionally.

Authors:  Andreas Kyriacou; Punam A Pabari; Jamil Mayet; Nicholas S Peters; D Wyn Davies; P Boon Lim; David Lefroy; Alun D Hughes; Prapa Kanagaratnam; Darrel P Francis; Zachary I Whinnett
Journal:  Int J Cardiol       Date:  2013-10-16       Impact factor: 4.164

4.  Evidence that conflict regarding size of haemodynamic response to interventricular delay optimization of cardiac resynchronization therapy may arise from differences in how atrioventricular delay is kept constant.

Authors:  S M Afzal Sohaib; Andreas Kyriacou; Siana Jones; Charlotte H Manisty; Jamil Mayet; Prapa Kanagaratnam; Nicholas S Peters; Alun D Hughes; Zachary I Whinnett; Darrel P Francis
Journal:  Europace       Date:  2015-04-07       Impact factor: 5.214

5.  Evaluation of the therapeutic effects of QuickOpt optimization in Chinese patients with chronic heart failure treated by cardiac resynchronization.

Authors:  Ji Yan; Shu Zhang; Dejia Huang; Xiaolin Xue; Jing Xu; Qianmin Tao; Weize Zhang; Zheng Zhang; Wei Hua; Yanchun Liang; Baopeng Tang; Wei Xu; Geng Xu; Xuejun Ren; Jingfeng Wang; Tao Guo; Shaobin Jia; Yugang Dong; Hong Jiang; Guosheng Fu; Liguang Zhu; Lin Chen; Fuli Tian; Feng Ling; Jianmei Li; Xiaoyong Qi; Yinglu Hao; Yutang Wang; Liangrong Zheng; Xiaoqun Pu; Farong Shen; Guangping Li; Hui Li; Fang Peng
Journal:  Sci Rep       Date:  2018-03-09       Impact factor: 4.379

6.  Optimizing atrio-ventricular delay in pacemakers using potentially implantable physiological biomarkers.

Authors:  Daniel Keene; Alejandra A Miyazawa; Monika Johal; Ahran D Arnold; Nadine Ali; Khulat A Saqi; Katherine March; Leah Burden; Darrel P Francis; Zachary I Whinnett; Matthew J Shun-Shin
Journal:  Pacing Clin Electrophysiol       Date:  2022-01-28       Impact factor: 1.912

7.  British randomised controlled trial of AV and VV optimization ("BRAVO") study: rationale, design, and endpoints.

Authors:  Zachary I Whinnett; S M Afzal Sohaib; Siana Jones; Andreas Kyriacou; Katherine March; Emma Coady; Jamil Mayet; Alun D Hughes; Michael Frenneaux; Darrel P Francis
Journal:  BMC Cardiovasc Disord       Date:  2014-04-03       Impact factor: 2.298

8.  Comparison of different invasive hemodynamic methods for AV delay optimization in patients with cardiac resynchronization therapy: implications for clinical trial design and clinical practice.

Authors:  Zachary I Whinnett; Darrel P Francis; Arnaud Denis; Keith Willson; Patrizio Pascale; Irene van Geldorp; Maxime De Guillebon; Sylvain Ploux; Kenneth Ellenbogen; Michel Haïssaguerre; Philippe Ritter; Pierre Bordachar
Journal:  Int J Cardiol       Date:  2013-03-05       Impact factor: 4.164

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.